UniProt ID | COR1C_HUMAN | |
---|---|---|
UniProt AC | Q9ULV4 | |
Protein Name | Coronin-1C | |
Gene Name | CORO1C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 474 | |
Subcellular Localization | Cell membrane . Cell projection, lamellipodium . Cytoplasm, cytoskeleton . All isoforms localize in a diffuse and punctate pattern in the cytosol and are highly enriched in F-actin-rich areas. Isoform 3 colocalizes with the thin filaments of the sarc | |
Protein Description | May be involved in cytokinesis, motility, and signal transduction.; Isoform 3: Involved in myogenic differentiation.. | |
Protein Sequence | MRRVVRQSKFRHVFGQAVKNDQCYDDIRVSRVTWDSSFCAVNPRFVAIIIEASGGGAFLVLPLHKTGRIDKSYPTVCGHTGPVLDIDWCPHNDQVIASGSEDCTVMVWQIPENGLTLSLTEPVVILEGHSKRVGIVAWHPTARNVLLSAGCDNAIIIWNVGTGEALINLDDMHSDMIYNVSWNRNGSLICTASKDKKVRVIDPRKQEIVAEKEKAHEGARPMRAIFLADGNVFTTGFSRMSERQLALWNPKNMQEPIALHEMDTSNGVLLPFYDPDTSIIYLCGKGDSSIRYFEITDESPYVHYLNTFSSKEPQRGMGYMPKRGLDVNKCEIARFFKLHERKCEPIIMTVPRKSDLFQDDLYPDTAGPEAALEAEEWFEGKNADPILISLKHGYIPGKNRDLKVVKKNILDSKPTANKKCDLISIPKKTTDTASVQNEAKLDEILKEIKSIKDTICNQDERISKLEQQMAKIAA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
19 | Malonylation | HVFGQAVKNDQCYDD HHHCHHHCCCCCCCC | 58.80 | 26320211 | |
19 | Acetylation | HVFGQAVKNDQCYDD HHHCHHHCCCCCCCC | 58.80 | 25953088 | |
25 | Ubiquitination | VKNDQCYDDIRVSRV HCCCCCCCCEEEEEE | 53.11 | - | |
28 | Methylation | DQCYDDIRVSRVTWD CCCCCCEEEEEEEEC | 27.61 | - | |
187 | Phosphorylation | VSWNRNGSLICTASK EEECCCCCEEEEECC | 20.36 | 26657352 | |
194 | Malonylation | SLICTASKDKKVRVI CEEEEECCCCCEEEE | 71.72 | 26320211 | |
194 | Acetylation | SLICTASKDKKVRVI CEEEEECCCCCEEEE | 71.72 | 25953088 | |
203 | Ubiquitination | KKVRVIDPRKQEIVA CCEEEECHHHHHHHH | 33.95 | - | |
240 | Phosphorylation | FTTGFSRMSERQLAL ECCCCCCCCHHHHHH | 4.77 | 27251275 | |
291 | Methylation | GKGDSSIRYFEITDE CCCCCEEEEEEECCC | 31.84 | - | |
292 | Phosphorylation | KGDSSIRYFEITDES CCCCEEEEEEECCCC | 12.14 | 28331001 | |
296 | Phosphorylation | SIRYFEITDESPYVH EEEEEEECCCCCCEE | 26.90 | 28152594 | |
299 | Phosphorylation | YFEITDESPYVHYLN EEEECCCCCCEEEEE | 25.08 | 28152594 | |
301 | Phosphorylation | EITDESPYVHYLNTF EECCCCCCEEEEEEC | 14.78 | 22115753 | |
304 | Phosphorylation | DESPYVHYLNTFSSK CCCCCEEEEEECCCC | 7.51 | 28152594 | |
307 | Phosphorylation | PYVHYLNTFSSKEPQ CCEEEEEECCCCCCC | 23.46 | 28152594 | |
309 | Phosphorylation | VHYLNTFSSKEPQRG EEEEEECCCCCCCCC | 38.16 | 28152594 | |
310 | Phosphorylation | HYLNTFSSKEPQRGM EEEEECCCCCCCCCC | 36.53 | 28152594 | |
311 | Ubiquitination | YLNTFSSKEPQRGMG EEEECCCCCCCCCCC | 72.69 | 21906983 | |
317 | Ubiquitination | SKEPQRGMGYMPKRG CCCCCCCCCCCCCCC | 3.66 | - | |
317 | Sulfoxidation | SKEPQRGMGYMPKRG CCCCCCCCCCCCCCC | 3.66 | 30846556 | |
320 | Sulfoxidation | PQRGMGYMPKRGLDV CCCCCCCCCCCCCCC | 2.33 | 30846556 | |
322 | Ubiquitination | RGMGYMPKRGLDVNK CCCCCCCCCCCCCCH | 42.44 | - | |
328 | Ubiquitination | PKRGLDVNKCEIARF CCCCCCCCHHHHHHH | 42.82 | - | |
329 | Acetylation | KRGLDVNKCEIARFF CCCCCCCHHHHHHHH | 32.85 | 26051181 | |
329 | Ubiquitination | KRGLDVNKCEIARFF CCCCCCCHHHHHHHH | 32.85 | - | |
329 | Malonylation | KRGLDVNKCEIARFF CCCCCCCHHHHHHHH | 32.85 | 26320211 | |
335 | Ubiquitination | NKCEIARFFKLHERK CHHHHHHHHHHCCCC | 4.71 | - | |
337 | Acetylation | CEIARFFKLHERKCE HHHHHHHHHCCCCCE | 46.34 | 25825284 | |
343 | Glutathionylation | FKLHERKCEPIIMTV HHHCCCCCEEEEEEC | 10.61 | 22555962 | |
348 | Sulfoxidation | RKCEPIIMTVPRKSD CCCEEEEEECCCHHH | 2.98 | 30846556 | |
353 | Ubiquitination | IIMTVPRKSDLFQDD EEEECCCHHHCCCCC | 42.10 | - | |
354 | Phosphorylation | IMTVPRKSDLFQDDL EEECCCHHHCCCCCC | 40.60 | 27251275 | |
364 | Ubiquitination | FQDDLYPDTAGPEAA CCCCCCCCCCCHHHH | 35.31 | 21890473 | |
389 | Phosphorylation | NADPILISLKHGYIP CCCCEEEEEECCCCC | 28.11 | 21712546 | |
390 | Acetylation | ADPILISLKHGYIPG CCCEEEEEECCCCCC | 3.63 | 19608861 | |
391 | Ubiquitination | DPILISLKHGYIPGK CCEEEEEECCCCCCC | 28.35 | 21890473 | |
391 | Acetylation | DPILISLKHGYIPGK CCEEEEEECCCCCCC | 28.35 | 25953088 | |
394 | Phosphorylation | LISLKHGYIPGKNRD EEEEECCCCCCCCCC | 12.03 | 28152594 | |
397 | Ubiquitination | LKHGYIPGKNRDLKV EECCCCCCCCCCCHH | 30.25 | - | |
398 | Ubiquitination | KHGYIPGKNRDLKVV ECCCCCCCCCCCHHH | 43.38 | - | |
398 | Malonylation | KHGYIPGKNRDLKVV ECCCCCCCCCCCHHH | 43.38 | 26320211 | |
407 | Ubiquitination | RDLKVVKKNILDSKP CCCHHHHHHHCCCCC | 37.30 | - | |
412 | Phosphorylation | VKKNILDSKPTANKK HHHHHCCCCCCCCCC | 36.77 | 20068231 | |
413 | Ubiquitination | KKNILDSKPTANKKC HHHHCCCCCCCCCCC | 46.16 | - | |
413 | Acetylation | KKNILDSKPTANKKC HHHHCCCCCCCCCCC | 46.16 | 23954790 | |
413 | Malonylation | KKNILDSKPTANKKC HHHHCCCCCCCCCCC | 46.16 | 26320211 | |
415 | Phosphorylation | NILDSKPTANKKCDL HHCCCCCCCCCCCCE | 46.74 | 20068231 | |
418 | Acetylation | DSKPTANKKCDLISI CCCCCCCCCCCEEEC | 52.92 | 25953088 | |
420 | Glutathionylation | KPTANKKCDLISIPK CCCCCCCCCEEECCC | 5.70 | 22555962 | |
424 | Phosphorylation | NKKCDLISIPKKTTD CCCCCEEECCCCCCC | 39.89 | 28348404 | |
430 | Phosphorylation | ISIPKKTTDTASVQN EECCCCCCCCHHHHC | 39.99 | 25159151 | |
434 | Phosphorylation | KKTTDTASVQNEAKL CCCCCCHHHHCHHHH | 26.74 | 25159151 | |
440 | Acetylation | ASVQNEAKLDEILKE HHHHCHHHHHHHHHH | 50.74 | 20167786 | |
440 | Malonylation | ASVQNEAKLDEILKE HHHHCHHHHHHHHHH | 50.74 | 26320211 | |
444 | Ubiquitination | NEAKLDEILKEIKSI CHHHHHHHHHHHHHH | 7.13 | 21890473 | |
444 | Ubiquitination | NEAKLDEILKEIKSI CHHHHHHHHHHHHHH | 7.13 | 21890473 | |
446 | Malonylation | AKLDEILKEIKSIKD HHHHHHHHHHHHHHH | 64.15 | 26320211 | |
446 | Ubiquitination | AKLDEILKEIKSIKD HHHHHHHHHHHHHHH | 64.15 | 19608861 | |
446 | Acetylation | AKLDEILKEIKSIKD HHHHHHHHHHHHHHH | 64.15 | 19608861 | |
447 | Phosphorylation | KLDEILKEIKSIKDT HHHHHHHHHHHHHHH | 52.80 | 27642862 | |
449 | Malonylation | DEILKEIKSIKDTIC HHHHHHHHHHHHHHC | 47.41 | 26320211 | |
452 | Acetylation | LKEIKSIKDTICNQD HHHHHHHHHHHCCHH | 56.78 | 26051181 | |
452 | Acetylation | LKEIKSIKDTICNQD HHHHHHHHHHHCCHH | 56.78 | - | |
452 | Malonylation | LKEIKSIKDTICNQD HHHHHHHHHHHCCHH | 56.78 | 26320211 | |
456 | Glutathionylation | KSIKDTICNQDERIS HHHHHHHCCHHHHHH | 3.98 | 22555962 | |
463 | Phosphorylation | CNQDERISKLEQQMA CCHHHHHHHHHHHHH | 37.09 | 22355754 | |
464 | Acetylation | NQDERISKLEQQMAK CHHHHHHHHHHHHHH | 54.38 | 26051181 | |
464 | Ubiquitination | NQDERISKLEQQMAK CHHHHHHHHHHHHHH | 54.38 | - | |
471 | Ubiquitination | KLEQQMAKIAA---- HHHHHHHHHHC---- | 27.77 | 21890473 | |
477 | Ubiquitination | AKIAA---------- HHHHC---------- | - | ||
477 | Phosphorylation | AKIAA---------- HHHHC---------- | 27251275 | ||
499 | Acetylation | -------------------------------- -------------------------------- | 19608861 | ||
499 | Ubiquitination | -------------------------------- -------------------------------- | - | ||
517 | Ubiquitination | -------------------------------------------------- -------------------------------------------------- | - | ||
524 | Ubiquitination | --------------------------------------------------------- --------------------------------------------------------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
463 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of COR1C_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COR1C_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-337 AND LYS-446, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-301, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-301, AND MASSSPECTROMETRY. |